Report Links Osteoporosis Drug to Esophagus Cancer

There could be some worrying news for the tens of millions of Americans currently taking Fosamax. A brief report published today in the New England Journal of Medicine suggests a possible link between the osteoporosis drug and the development of esophageal cancer. The report, written by U.S. Food and Drug Administration official Diane Wysowski and published in the current New England Journal of Medicine, reveals that the FDA received 23 reports of esophageal cancer possibly linked to the drug...Full Story
Commenting on this article is closed.